Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

5 Stocks To Watch: AKTX, CARA, CLNE, NBRV, VRA

Published 03/14/2019, 01:02 AM
Updated 07/09/2023, 06:31 AM

Akari Therapeutics, Plc (AKTX)

AKTX soared 224.18%, up 4.08 to 5.90 on Wednesday, on 81 million shares and in after hours it’s up nearly a dollar or 16%. This stock may have a follow-through session. If you take a look at the way this stock closed at the upper end of the range on 81 million shares, it would not shock me to see 8, 9, or even 10 in the next day or two.

Cara Therapeutics, Inc. (CARA)

CARA exploded out of a consolidation, wedge-type pattern on Wednesday, and went out through resistance at about the 19 range, closing up 2.05, or 12%, to 19.48, on 3.5 million shares. That’s really good volume for that stock. It’s the best we’ve seem since June, which leads me to believe that 21, 22, even higher than that could be targets. Let’s say 21 and 24 are the targets going forward. Clean Energy Fuels Corp. (CLNE) bounced 65 cents, or 29%, to 2.92, with a huge volume of 8.4 million shares on Wednesday, the largest volume since May or June of last year. This could trigger another big move. I’m looking for this stock to test and take out the 3.10-3.15 range. If it does, the target is 3.50-4.00.

Denali Therapeutics Inc. (DNLI)

DNLI took out multiple tops on Wednesday with a pop of 2.17, or 10%, to 24.38, on 1.2 million shares. It looks to me like it could extend. A test of the old highs may be in order at 25 3/4. It might get there on Thursday.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Nabriva Therapeutics plc (NBRV)

NBRV broke out of an inverse head-and-shoulders on Wednesday, with a kind of extended platform with a pop of 38 cents, or 15.64%, to 2.81, on 1.7 million shares. Going forward, targets are 3 1/4-1/2 and 4 1/2.

Vera Bradley, Inc. (VRA)

VRA with a big breakaway move on earnings on Wednesday, got up to resistance tells most of it. It was up 2.44, or 21.82%, to 13.62, on 3.2 million shares. It was a significant day on volume. There’s resistance here. I would like to see it back and fill. My next target is 16, followed by 17 1/2-18

Stocks on the long side

Aurora Cannabis Inc. (ACB), Akari Therapeutics, Plc (AKTX), Axsome Therapeutics, Inc. (AXSM), Cara Therapeutics, Inc. (CARA), Clean Energy Fuels Corp. (CLNE), Conatus Pharmaceuticals Inc. (CNAT), California Resources Corporation (CRC), Denali Therapeutics Inc. (DNLI), Everi Holdings Inc. (EVRI), Exelixis, Inc. (EXEL), Fluidigm Corporation (FLDM), Guardant Health, Inc. (GH), Jounce Therapeutics, Inc. (JNCE), Lexicon Pharmaceuticals, Inc. (LXRX), Momo Inc. (MOMO), Nabriva Therapeutics plc (NBRV), Natera, Inc. (NTRA), NVIDIA Corporation (NASDAQ:NVDA), Puma Biotechnology, Inc. (PBYI), Quantenna Communications, Inc. (QTNA), Pareteum Corporation (TEUM), Vera Bradley, Inc. (VRA), and YETI Holdings, Inc. (YETI).

Watch video here.

Latest comments

Hey harry what about CLNE?
Sorry i see it now
Do watch anyone besides harry?
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.